The echinoderm microtubule-associated protein-like 4- anaplastic lymphoma kinase (EML4-ALK) fusion has emerged as the second most important driver oncogene in lung cancer and the first targetable fusion oncokinase to be identified in 4%-6% of lung adenocarcinomas3,.4 This evidence concerns the gene EML4 and lung carcinoma.